Literature DB >> 26294217

Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses.

Theodoros N Sergentanis1, Flora Zagouri2, Gerasimos Tsilimidos1, Anastasia Tsagianni1, Melina Tseliou1, Meletios A Dimopoulos3, Theodora Psaltopoulou1.   

Abstract

The epidemiology of multiple myeloma (MM) is an increasingly investigated field, with many controversies. This systematic review aims to synthesize meta-analyses examining risk factors for MM so as to provide a comprehensive, parsimonious summary of the current evidence. Eligible meta-analyses were sought in PubMed adopting a predefined algorithm, without any restriction of publication language; end-of-search date was October 10, 2014. The selection of eligible studies and data extraction were performed by working in pairs, independently and blindly to each other; in case of disagreement, consensus with the whole team was reached. Among the 22 ultimately included meta-analyses, 9 examined occupational factors, 4 assessed aspects of lifestyle (smoking, alcohol, body mass index), 5 evaluated the presence of other diseases, and 4 addressed genetic factors as potential risk factors of MM. A vast compendium of significant associations arose, including farming, occupation as a firefighter, occupation as a hairdresser, exposures to chemicals or pesticides, overweight and obesity, patterns of alcohol intake, pernicious anemia, ankylosing spondylitis, gene promoter methylation, and polymorphisms. In conclusion, MM is a multifactorial disease, encompassing a wide variety of risk factors that span numerous life aspects. Further accumulation of evidence through meta-analyses is anticipated in this rapidly growing field.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Meta-analysis; Multiple myeloma; Risk factors; Systematic review

Mesh:

Year:  2015        PMID: 26294217     DOI: 10.1016/j.clml.2015.06.003

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  18 in total

1.  Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Authors:  Ying Chen; David R Lairson; Wenyaw Chan; Xianglin L Du
Journal:  Med Oncol       Date:  2017-08-03       Impact factor: 3.064

2.  Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study.

Authors:  Wei-De Lin; Fuu-Jen Tsai
Journal:  Biomed Hub       Date:  2021-11-29

3.  Hypertensive nephropathy is associated with an increased risk of myeloma, skin, and renal cancer.

Authors:  James Goya Heaf; Alastair Hansen; Gunnar Hellmund Laier
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

4.  Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Authors:  E Stagnaro; S Parodi; A Seniori Costantini; P Crosignani; L Miligi; O Nanni; S Piro; V Ramazzotti; S Rodella; R Tumino; C Vindigni; P Vineis
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

5.  Mesenchymal Stem Cells Inhibit the Effects of Dexamethasone in Multiple Myeloma Cells.

Authors:  Mingyang Deng; Huan Yuan; Hongling Peng; Sufang Liu; Xiang Xiao; Zhihua Wang; Guangsen Zhang; Han Xiao
Journal:  Stem Cells Int       Date:  2022-04-04       Impact factor: 5.443

Review 6.  Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.

Authors:  Patrizia Mondello; Salvatore Cuzzocrea; Michele Navarra; Michael Mian
Journal:  Oncotarget       Date:  2017-03-21

7.  Multiple myeloma associated with an Evan's syndrome.

Authors:  Achour Bechir; Regaieg Haifa; Ben Sayed Nesrine; Bouslema Emna; Mejdoub Senda; Achour Asma; Bouatay Bouzouita Amina; Senda Mrabet; Ben Youssef Yosra; Kortas Mondher; Khelif Abderrahim
Journal:  Pan Afr Med J       Date:  2016-11-01

8.  Epidemiology of multiple myeloma in 17 Latin American countries: an update.

Authors:  Maria Paula Curado; Max M Oliveira; Diego R M Silva; Dyego L B Souza
Journal:  Cancer Med       Date:  2018-03-24       Impact factor: 4.452

9.  Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway.

Authors:  Alem A Belachew; Xifeng Wu; Rashida Callender; Rosalie Waller; Robert Z Orlowski; Celine M Vachon; Nicola J Camp; Elad Ziv; Michelle A T Hildebrandt
Journal:  Cancer Epidemiol       Date:  2021-06-30       Impact factor: 2.890

10.  TRAF3 deficiency promotes metabolic reprogramming in B cells.

Authors:  Nurbek Mambetsariev; Wai W Lin; Alicia M Wallis; Laura L Stunz; Gail A Bishop
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.